Patent US5680174A successfully refreshed from Google Patents.
Patent US4599361A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4599361A Expired / Lapsed US ⏱️ 0.0 years remaining

Hydroxamic acid based collagenase inhibitors

Assignee: GD Searle LLC
•
Filing: 1985-09-10
•
Granted: 1986-07-08
•
Expires: 2005-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure relates to a novel class of hydroxamic acid based collagenase inhibitor derivatives. The disclosure further relates to pharmaceutical compositions containing such compounds and to the use of such compounds and compositions in the treatment of collagenase induced diseases.

Inventors

  • 👤 Jonathan P. Dickens
  • 👤 David K. Donald
  • 👤 Geoffrey Kneen
  • 👤 William R. McKay

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 02:00
CPC Classifications
C; C07; C07C; C07C233/00; C07C233/01; C07C233/02; C07C237/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 112 words
A compound of the formula ##STR26## wherein R 1 is C 1 -C 6 alkyl; R 2 is C 1 -C 6 alkyl, benzyl, benzyloxybenzyl, (C 1 -C 6 alkoxy)benzyl or benzyloxy(C 1 -C 6 alkyl); a is a chiral center with optional R or S stereochemistry; A is a ##STR27## group or a --(CR 3 ═CR 4 )-- group wherein b and c are chiral centers with optional R or S stereochemistry; R 3 is hydrogen, C 1 -C 6 alkyl, phenyl or phenyl(C 1 -C 6 alkyl) and R 4 is hydrogen or C 1 -C 6 alkyl, phenyl(C 1 -C 6 alkyl), cycloalkyl or cycloalkyl(C 1 -C 6 alkyl).
Claim 2
Dependent Claim 112 words
A compound of the formula ##STR26## wherein R 1 is C 1 -C 6 alkyl; R 2 is C 1 -C 6 alkyl, benzyl, benzyloxybenzyl, (C 1 -C 6 alkoxy)benzyl or benzyloxy(C 1 -C 6 alkyl); a is a chiral center with optional R or S stereochemistry; A is a ##STR27## group or a --(CR 3 ═CR 4 )-- group wherein b and c are chiral centers with optional R or S stereochemistry; R 3 is hydrogen, C 1 -C 6 alkyl, phenyl or phenyl(C 1 -C 6 alkyl) and R 4 is hydrogen or C 1 -C 6 alkyl, phenyl(C 1 -C 6 alkyl), cycloalkyl or cycloalkyl(C 1 -C 6 alkyl).
Claim 3
Dependent Claim 13 words
A compound according to claim 1 wherein chiral center a has S stereochemistry.
Claim 4
Dependent Claim 11 words
A compound according to claim 2 wherein A is a ##STR28##
Claim 5
Dependent Claim 15 words
A compound according to claim 3 wherein R 2 is (C 1 -C 6 alkoxy)benzyl.
Claim 6
Dependent Claim 36 words
A compound according to claim 4 wherein R 2 is 4-methoxybenzyl, R 4 is C 1 -C 4 alkyl and R 3 is hydrogen, C 1 -C 4 alkyl, phenyl or phenyl(C 1 -C 6 alkyl).
Claim 7
Dependent Claim 22 words
A compound according to claim 5 wherein R 1 is methyl, R 3 is hydrogen or methyl and R 4 is 2-methylpropyl.
Claim 8
Dependent Claim 11 words
A compound according to claim 6 wherein R 3 is hydrogen.
Claim 9
Dependent Claim 102 words
A compound according to claim 7 having the following NMR spectrum: NMR (d 6 -DMSO) 0.7-0.9 (6H, m, {CH 3 } 2 CH); 1.3 (1H, m, {CH 3 } 2 CH); 1.9-2.2 (3H, 2xm, CH 2 CH); 2.50 (3H, m, CHCH 2 CO, +CH 2 CHCO); 2.6 (2H, m, ArCH 2 ); 2.6 (3H, d, NHCH 3 ); 3.7 (3H, s, OCH 3 ); 4.3-4.4 (1H, m, ArCH 3 CH); 6.75-7.1 (4H, 2xd, J=8 Hz, aromatic); 7.9 (1H, m, NHCH 3 ); 8.05 (1H, d, CONHCH); 8.65 (1H, s, NHOH {D 2 O exchange}); 10.4 (1H, s, NHOH {D 2 O exchange}).
Claim 10
Dependent Claim 11 words
A compound according to claim 6 wherein R 3 is methyl.
Claim 11
Dependent Claim 106 words
A compound according to claim 9 having the following NMR spectrum: NMR (d 6 -DMSO) 0.64-0.92 (9H, m, {CH 3 } 2 CHCH 2 ); 1.30 (3H, m, CH 3 CH); 2.20-2.40 (2H, m, CH 3 CH and CH 3 CHCH); 2.45 (2H, m, ArCH 2 ); 2.55 (3H, d, J=4 Hz, NHCH 3 ); 3.68 (3H, s, OCH 3 ); 4.45 (1H, m, ArCH 2 CH); 6.80 and 7.16 (4H, two d's, J=7 Hz, aromatic); 7.72 (1H, m, NHCH 3 ); 8.18 (1H, d, J=7 Hz, CONHCH 3 ); 8.72 (1H, s, NHOH {D 2 O exchange}); 10.37 (1H, s, NHOH {D 2 O exchange}).
Claim 12
Dependent Claim 28 words
A method of promoting an antiarthritic effect in a mammal in need thereof comprising administering thereto a collagenase inhibiting effective amount of a compound according to claim 1.

References Cited (Backward Citations)

US3247197A Cited
US3471476A Cited
US4077998A Cited
US4105789A Cited
US4028401A Cited
US4397867A Cited
US4419365A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-07 1990-01-06 1990-07-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-07 1994-01-06 1994-07-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-07 1998-01-06 1998-07-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag